Dear colleagues & guests,
On behalf of the Organizing Committee, I would like to express a warm welcome to all participants of the 3rd edition of the Pulmonary Hypertension Teaching Course, organized between 7-8 of December, 2022 in Targu Mures, Romania.
We are very pleased to invite you to the largest gathering of experts active in the field of PAH and CTEPH from Austria, Czech Republic, Poland, United States of America, and Romania.
The increased awareness related to the diseases, evidence-based management strategies, targeted therapies, surgical (PEA) and interventional treatment (BPA) can offer new perspectives, improving the outcomes of PAH and CTEPH patients.
Progresses in surgical and medical treatment continues to improve the outcome of patients with CTEPH. In addition, novel treatment approaches such as pulmonary balloon angioplasty may offer new perspectives. The conference program will present the latest and most significant developments in basic and clinical research, imaging and diagnosis and, of course, medical, surgical and interventional (BPA) treatment.
We trust that this Course will provide a vibrant and interactive opportunity for the exchange of state-of-the-art knowledge regarding these two progressive and devastating medical conditions, to raise awareness of PAH and CTEPH and to help scientists and clinicians translate the latest findings into improvements in patient care. It is our aim that the major strength of the meeting will be the opportunity for all participants to interact and exchange ideas, for facilitating research, interdisciplinary collaboration focusing international networking.
The course format is structured in lectures, panel discussions and case presentations. Recordings of each session will be made available after the event to registered participants.Finally, we hope that you will enjoy our meeting, and with your invaluable contribution it will be an informative and dynamic event.
Now on-line registration is open and free.
Course is beeing planned in compliance with continuing medical education accreditation policies and procedures and is accredited with CME credits by Romanian College of Physicians.
Finally, we hope that you will enjoy this course and our beatiful city, Targu Mures.
Prof. Ioan TILEA
An inspiring place
Situated on a hill that overlooks the city, an imposing building has a distinct impact on the lives of the citizens – The George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures.
Dr. Darocha is Associate Professor in Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology of Centre of Postgraduate Medical Education in Warsaw, Poland. Specialist of internal medicine and cardiology. PhD degree in the field of chronic thromboembolic pulmonary hypertension. Master Degree in ”Pulmonary Vascular Diseases”, Università di Bologna, Bologna, Italy. His research interests are related to role of invasive procedures in diagnosis and treatment of pulmonary vascular diseases. In 2013 introduced balloon pulmonary angioplasty (BPA) program for chronic thromboembolic pulmonary hypertension in Poland.
Dr. Preston is Associate Professor of Medicine at Tufts University School of Medicine and Chair of the Pulmonary Hypertension Center of the Pulmonary, Critical Care and Sleep Division at Tufts Medical Center in Boston, MA. She completed her residency in internal medicine and fellowship in pulmonary and critical care medicine at Brown University in Providence, RI. She is the Chair of the Pulmonary Professional Community and past Chair of the Pulmonary Hypertension and Chronic Thromboembolic Disease Interdisciplinary Committee of the International Heart and Lung Transplant Society. She is a member of several research grand review committees and participated in numerous clinical trials in pulmonary hypertension. She has co-authored over 80 peer-reviewed publications.
Dr. Armand Gottlieb is a third year pulmonary and critical care medicine fellow at Tufts Medical Center in Boston, MA, USA. His clinical interests include cardiac critical care, mechanical circulatory support, and pulmonary vascular disease. He is passionate about medical education, and has spent much of his time in fellowship developing lectures and simulation sessions for medical students and internal medicine residents. Outside of the hospital he enjoys spending time in the outdoors with his wife and three young children.
Prof. Pavel Jansa was educated at the Charles University in Prague, First Faculty of Medicine (1996). He specialised in internal medicine in 1999 and cardiology in 2005. He is Chief of the Centre for Pulmonary Hypertension at the Department of Cardiology and Angiology, General University Hospital in Prague, and Professor at the First Faculty of Medicine, Charles University, Prague. Dr. Jansa is chairman of the Working Group on Pulmonary Circulation of the Czech Society of Cardiology. His research interests include epidemiology of pulmonary hypertension, coagulation disorders in pulmonary hypertension, small-vessel disease in chronic thromboembolic pulmonary hypertension, and balloon pulmonary angioplasty. He has served as the principal investigator and steering committee member of pulmonary hypertension clinical trials. Dr. Jansa has co-authored research articles published in the New England Journal of Medicine, Lancet, European Heart Journal, European Respiratory Journal, Circulation, Journal of the American College of Cardiology, Chest, Pulmonary Circulation and numerous other peer-reviewed medical journals.
Marcin Kurzyna is the Head of Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology of Centre of Postgraduate Medical Education in Warsaw. He is a specialist in internal medicine and cardiology and has a PhD in respiratory medicine. His research interests are related to role of invasive procedures in diagnosis and treatment of pulmonary vascular diseases.
Professor of Vascular Biology, Medical University of Vienna. Professor Irene Marthe Lang is a senior staff member at the Department of Cardiology, and deputy Chairwoman of the Department. Irene M. Lang, carried out her medical education and residency at the University of Vienna, before taking on a 5-year postdoctoral research fellowship at the University of California, which included a joint appointment with the Scripps Research Institute. Since 2004, she has been Professor of Vascular Biology at the Medical University of Vienna. Professor Lang is leading a clinical and experimental group in vascular medicine, with one focus on pulmonary vascular biology and right ventricular function. Professor Lang has been leading numerous studies in the cardiovascular field, including a trial on myocardial regeneration employing intramyocardial cell injections.
Dr Lang is an active interventional and structural cardiologist with a case load of >15,000, and an active researcher with >800 impact points and an h-Factor of 30. She was nominated by the World Medical Association as a “Caring Physician of the World” in 2006, Teacher of the Year at the Medical University of Vienna in 2013, and is past president of the Austrian Society of Cardiology. Dr Lang is part of the International CTEPH Association (ICA), with the objectives to increase awareness for CTEPH, foster worldwide collaboration among CTEPH centers, serve as platform for surgical centers, facilitate training of emerging CTEPH centers, and advance research and education in CTEPH. Dr Lang is directing an outpatient unit for pulmonary vascular disease at the Medical University of Vienna.
Graduated from the Medical University of Warsaw in 1978. Specialized in cardiology ad angiology. Former head of the Department of Pulmonary Circulation and Thromboembolic Diseases, Medical Center for Postgraduate Education, ECZ- Otwock.
Coordinator of ESC Guidelines for Diagnosis and Treatment of Pulmonary Embolism (2000, 2008, 2014), co-author of ESC/ERS guidelines on diagnosis and treatment of pulmonary hypertension (2004, 2009, 2015). Chairman of the Working Group on Pulmonary Circulation and Right Ventricular Function of the ESC (2004-2006). In the years 2004-2007 he presided over the Polish Cardiac Society and between 2010 and 2012 served as Vice-President of the European Society of Cardiology.
Main research interests: pulmonary circulation (acute pulmonary embolism, chronic thromboembolic pulmonary hypertension, pulmonary arterial hypertension), right ventricular function, thromboembolic diseases, cardiovascular imaging and cardiovascular biomarkers